UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
For the month of December 2019
Commission File Number 001-39005
SUNDIAL GROWERS INC.
(Registrant’s name)
#200, 919 - 11 Avenue SW
Calgary, AB T2R 1P3
Tel.: (403) 948-5227
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
SUNDIAL GROWERS INC. | ||||||
Date: December 19, 2019 | By: | /s/ James Keough | ||||
Name: | James Keough | |||||
Title: | Chief Financial Officer |
EXHIBIT
Exhibit | Description of Exhibit | |
99.1 | News Release dated December 19, 2019 - Sundial Announces 2020 Launch of Medical Cannabis Marketplace | |
Exhibit 99.1
Sundial Announces 2020 Launch of Medical Cannabis Marketplace
CALGARY, Dec. 19, 2019 /CNW/ - Sundial Growers Inc. (Nasdaq: SNDL) ("Sundial") is pleased to announce an initiative to enter the Canadian medical cannabis business with plans for an innovative e-commerce marketplace.
Navigating the process to access medical cannabis can be confusing to patients, and this content rich e-commerce platform aims to streamline the process. In delivering an elevated medical Cannabis experience to Canadians, Sundial will also leverage its research capabilities created by the 50% acquisition of Pathway Rx Inc. (PathwayRx). PathwayRx will implement learnings from its research to develop unique medical cannabis products targeted for use with specific medical conditions.
"This initiative is truly the launch pad for Sundial's Heal (medical) strategy and allows us to accelerate entry into the Canadian medical cannabis market by establishing trusted relationships with patients based on research, high-quality consistent products, accessibility and thoughtful customer care," said Torsten Kuenzlen, Sundial's Chief Executive Officer.
Sundial has entered into an agreement with a subsidiary of Empire Company Limited and their family of brands, including Sobeys, Safeway, Lawtons, Thrifty Foods, FreshCo, and Foodland to offer medical cannabis education, products and accessories to its pharmacy patients when the marketplace is launched.
This new platform will be available to patients across Canada starting in the summer of 2020.
For more information about Sundial, visit www.sndlgroup.com and follow on Twitter @SundialCannabis, Instagram @SundialCannabis, LinkedIn @SundialCannabis and Facebook @SundialCommunity.
About Sundial Growers Inc.
Sundial proudly crafts pioneering cannabis brands to Heal, Help and PlayTM:
Sundial has facilities in Canada and the United Kingdom and provides quality and consistent products consumers can trust.
In Canada, we grow 'craft-at-scale' cannabis using purpose-built modular facilities and award-winning genetics. Sundial's flagship production facility is located in Olds, Alberta with a second facility in Rocky View, Alberta. We have commenced construction of our next purpose-built facility in Merritt, British Columbia.
In the United Kingdom, we grow high-quality traceable plants, including hemp, ornamental flowers and edible herbs, in over 1.5 million square feet of state-of-the-art environmentally friendly, indoor facilities. Bridge Farm has three facilities in Spalding with another currently under construction.
We employ over 1,000 employees globally, full-time and seasonal, bringing economic benefits to the local communities in which we operate.
Forward-Looking Information Cautionary Statement
This news release includes statements containing certain "forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward looking statements in this release includes, but is not limited
to, the potential expansion plans of the Company in Canada, and statements regarding the future performance of the Company. Forward-looking
statements are frequently characterized by words such as "plan", "continue", "expect", "project",
"intend", "believe", "anticipate", "estimate", "may", "will", "potential",
"proposed" and other similar words, or statements that certain events or conditions "may" or "will"
occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections
contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions
and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other
factors that could cause actual events or results to differ materially from those projected in the forward-looking statements.
The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
SOURCE Sundial Growers Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/December2019/19/c6490.html
%CIK: 0001766600
For further information: Sophie Pilon, Corporate Communications Manager, Sundial Growers Inc., O: 1.587.327.2017, C: 1.403.815.7340, E: spilon@sundialgrowers.com
CO: Sundial Growers Inc.
CNW 07:30e 19-DEC-19